Organogenesis Holdings Inc. ORGO Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 0.5%-7.4pp | 7.9%— | —— | —— | —— | |
| Net margin | 0.5%-6.0pp | 6.6%+6.3pp | 0.2%+2.1pp | -1.9%+1.5pp | -3.5%-3.6pp | |
| EBITDA margin | 3.6%-7.0pp | 10.6%— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | 1.1%-12.0pp | 13.2%+12.8pp | 0.4%+3.7pp | -3.3%+2.8pp | -6.1%-6.4pp | |
| Return on assets | 0.6%-6.2pp | 6.8%+6.5pp | 0.2%+2.0pp | -1.8%+1.6pp | -3.4%-3.6pp | |
| Return on invested capital | 0.9%-11.5pp | 12.4%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 1×0.0× | 1×+0.1× | 1×0.0× | 1×0.0× | 1×0.0× | |
| Liquidity | ||||||
| Current ratio | 3.5×-0.1× | 3.6×+0.3× | 3.3×-0.6× | 4×-0.2× | 4.1×+0.4× | |
| Quick ratio | 3.2×-0.2× | 3.3×+0.4× | 2.9×-0.6× | 3.5×-0.2× | 3.7×+0.3× | |
| Cash ratio | 1.2×+0.3× | 0.9×+0.2× | 0.7×-0.4× | 1.1×-0.6× | 1.7×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×-0.1× | 0.3×+0.2× | 0.1×0.0× | 0.1×0.0× | 0.1×-0.4× | |
| Debt-to-assets | 0.1×-0.1× | 0.2×+0.1× | 0.1×0.0× | 0.1×0.0× | 0.1×-0.2× | |
| Net debt / EBITDA | -2.8×-2.8× | -0×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $1.91-17.0% | $2.30+18.2% | $1.95+12.0% | $1.74-9.4% | $1.92-3.7% | |
| Valuation | ||||||
| Market capitalization | $312.68M-23.7% | $657.4M+22.8% | $535.34M+22.0% | $438.91M-19.9% | $547.9M+36.2% | |
| Enterprise value | $260.72M-21.3% | $655.3M+30.2% | $503.19M+26.9% | $396.51M-15.5% | $469.51M+15.0% | |
| Price / earnings | 115×— | 17.8×-515× | 532.7×— | —— | —— | |
| Price / sales | 0.6×-0.3× | 1.2×0.0× | 1.2×+0.1× | 1×-0.2× | 1.2×+0.4× | |
| Price / book | 1.3×-0.4× | 2.2×+0.1× | 2.1×+0.2× | 1.9×-0.4× | 2.3×+0.7× | |
| EV / EBITDA | 14.1×— | 10.9×— | —— | —— | —— | |
| EV / sales | 0.5×-0.2× | 1.2×+0.1× | 1.1×+0.2× | 0.9×-0.1× | 1×+0.2× | |
| Earnings yield | 0.9%+4.7pp | 5.6%+5.4pp | 0.2%+2.1pp | -1.9%+1.0pp | -2.9%-3.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Organogenesis Holdings Inc.'s profit margins?
- Organogenesis Holdings Inc. (ORGO) runs a 75.9% gross margin and a 0.5% operating margin, with a 0.5% net margin.
- Where do Organogenesis Holdings Inc.'s ratios come from?
- Every ratio is computed from Organogenesis Holdings Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
